Abstract
Colon-type systemic chemotherapy is associated with longer survival in patients with high-grade mucinous appendiceal cancer with unresectable peritoneal metastases who were deemed surgical candidates but had a failed attempt of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (https://doi.org/10.1245/s10434-022-11894-6).